The most common adverse effects are nausea (occurring in 4060% of users during the first week), facial flushing within 3060 minutes post-injection, and spontaneous erections in male users even without sexual stimulation
GLP-1s dont directly cause prolapse, but rapid weight loss can affect the muscles and connective tissue holding your pelvic organs in place
This difference is consistent with patterns observed for semaglutide and tirzepatide across diabetic vs
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, tirzepatide) slow gastric emptying and commonly cause nausea, vomiting, and diarrhoea, particularly during treatment initiation
Concerns about a potential link between GLP-1 receptor agonists and pancreatic cancer emerged following preclinical animal studies and early case reports
Stress management techniques and exercising regularly have been shown to promote microbial diversity and cognitive resilience, potentially leading to improved neurocognitive outcomes following RT (Matei et al., 2023)
